Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andreas Hallqvist

Showing results (1-10 of 37) with videos related to

Pageof 4
Sort By:
Reports of Practical Oncology and Radiotherapy : Journal of Greatpoland Cancer Center in Poznan and Polish Society of Radiation Oncology|October 3, 2022
Stereotactic radiotherapy for brain metastases in patients with lung cancer; outcome and toxicity in clinical practiceKerstin Gunnarsson, Andreas Hallqvist
Journal of Neuro-Oncology|February 10, 2020
LINAC-based stereotactic radiosurgery versus hypofractionated stereotactic radiotherapy delivered in 3 or 5 fractions for vestibular schwannomas: comparative assessment from a single institutionLinn Söderlund Diaz, Andreas Hallqvist
Scandinavian Journal of Immunology|October 5, 2020
Immune checkpoint blockade and biomarkers of clinical response in non-small cell lung cancerAndreas Hallqvist, Anna Rohlin, Sukanya Raghavan
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|June 26, 2012
Health related quality of life in locally advanced NSCLC treated with high dose radiotherapy and concurrent chemotherapy or cetuximab--pooled results from two prospective clinical trialsAndreas Hallqvist, Bengt Bergman, Jan Nyman
Current Oncology (Toronto, Ont.)|May 27, 2022
Successful Treatment with Selpercatinib for Ectopic Cushing's Syndrome Due to Medullary Thyroid CancerOskar Ragnarsson, Marta Piasecka, Andreas Hallqvist
Acta Oncologica (Stockholm, Sweden)|September 14, 2007
Accelerated hyperfractionated radiotherapy and concomitant chemotherapy in small cell lung cancer limited-disease. Dose response, feasibility and outcome for patients treated in western Sweden, 1998-2004Andreas Hallqvist, Hillevi Rylander, Thomas Björk-Eriksson, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|June 8, 2023
Specific Uptake in the Bone Marrow Causes High Absorbed Red Marrow Doses During [Jens Hemmingsson, Johanna Svensson, Andreas Hallqvist, et al.
Acta Oncologica (Stockholm, Sweden)|October 17, 2024
Assessment of radiation pneumonitis and predictive factors in patients with locally advanced non-small cell lung cancer treated with chemoradiotherapyKerstin Gunnarsson, Louise Mövik, Niclas Pettersson, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 27, 2025
<sup>177</sup>Lu-DOTATATE in Combination with PARP Inhibitor Olaparib Is Feasible in Patients with Somatostatin-Positive Tumors: Results from the LuPARP Phase I TrialAndreas Hallqvist, Elva Brynjarsdóttir, Tomas Krantz, et al.
Journal of Applied Clinical Medical Physics|July 14, 2025
A semi-automated workflow for cohort-wise preparation of radiotherapy data for dose-response modeling, including autosegmentation of organs at riskLouise Mövik, Anna Bäck, Kerstin Gunnarsson, et al.
Pageof 4

Showing results (1-10 of 37) with videos related to

Sort By:
Pageof 4
Reports of Practical Oncology and Radiotherapy : Journal of Greatpoland Cancer Center in Poznan and Polish Society of Radiation Oncology|October 3, 2022
Stereotactic radiotherapy for brain metastases in patients with lung cancer; outcome and toxicity in clinical practiceKerstin Gunnarsson, Andreas Hallqvist
Journal of Neuro-Oncology|February 10, 2020
LINAC-based stereotactic radiosurgery versus hypofractionated stereotactic radiotherapy delivered in 3 or 5 fractions for vestibular schwannomas: comparative assessment from a single institutionLinn Söderlund Diaz, Andreas Hallqvist
Scandinavian Journal of Immunology|October 5, 2020
Immune checkpoint blockade and biomarkers of clinical response in non-small cell lung cancerAndreas Hallqvist, Anna Rohlin, Sukanya Raghavan
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|June 26, 2012
Health related quality of life in locally advanced NSCLC treated with high dose radiotherapy and concurrent chemotherapy or cetuximab--pooled results from two prospective clinical trialsAndreas Hallqvist, Bengt Bergman, Jan Nyman
Current Oncology (Toronto, Ont.)|May 27, 2022
Successful Treatment with Selpercatinib for Ectopic Cushing's Syndrome Due to Medullary Thyroid CancerOskar Ragnarsson, Marta Piasecka, Andreas Hallqvist
Acta Oncologica (Stockholm, Sweden)|September 14, 2007
Accelerated hyperfractionated radiotherapy and concomitant chemotherapy in small cell lung cancer limited-disease. Dose response, feasibility and outcome for patients treated in western Sweden, 1998-2004Andreas Hallqvist, Hillevi Rylander, Thomas Björk-Eriksson, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|June 8, 2023
Specific Uptake in the Bone Marrow Causes High Absorbed Red Marrow Doses During [Jens Hemmingsson, Johanna Svensson, Andreas Hallqvist, et al.
Acta Oncologica (Stockholm, Sweden)|October 17, 2024
Assessment of radiation pneumonitis and predictive factors in patients with locally advanced non-small cell lung cancer treated with chemoradiotherapyKerstin Gunnarsson, Louise Mövik, Niclas Pettersson, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 27, 2025
<sup>177</sup>Lu-DOTATATE in Combination with PARP Inhibitor Olaparib Is Feasible in Patients with Somatostatin-Positive Tumors: Results from the LuPARP Phase I TrialAndreas Hallqvist, Elva Brynjarsdóttir, Tomas Krantz, et al.
Journal of Applied Clinical Medical Physics|July 14, 2025
A semi-automated workflow for cohort-wise preparation of radiotherapy data for dose-response modeling, including autosegmentation of organs at riskLouise Mövik, Anna Bäck, Kerstin Gunnarsson, et al.
Pageof 4